Eltrombopag Tablet Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets & Oral Powder for Oral Suspension
Available Strengths: Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet
Reference Brands: Promacta,Revolade
Category: Anemia
Eltrombopag is an oral thrombopoietin receptor agonist used to treat chronic ITP, severe aplastic anemia, and hepatitis C-related thrombocytopenia. Marketed as Promacta and Revolade, it boosts platelet production and reduces transfusion needs. Ideal for pharma B2B sourcing.
Product Description:
Eltrombopag is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and hepatitis C-associated thrombocytopenia. Marketed globally as Promacta (US) and Revolade (EU/Worldwide), it stimulates platelet production and reduces bleeding risk. Available in GMP-certified oral tablets and pediatric suspension, Eltrombopag is a high-demand product in hematology. Ideal for pharmaceutical wholesalers, importers, and B2B buyers seeking reliable sourcing of specialty medicines. We offer bulk supply, export support, and regulatory documentation. Partner with us for competitive pricing and global delivery of Eltrombopag. Contact us today to secure your supply of Eltrombopag for pharma B2B needs.
Eltrombopag Tablet — third party manufacturing & bulk supply
Eltrombopag Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Eltrombopag Tablet is supplied as Oral Tablets & Oral Powder for Oral Suspension — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Eltrombopag Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Eltrombopag Tablet →Frequently Asked Questions
Eltrombopag is used to increase platelet counts in patients with chronic immune thrombocytopenia (ITP), thrombocytopenia caused by chronic hepatitis C, and severe aplastic anaemia. It helps stimulate platelet production in the bone marrow.
It is made from the active molecule eltrombopag olamine, a small-molecule thrombopoietin receptor agonist that binds to the TPO receptor and promotes platelet growth.
Its main trade names are Promacta and Revolade in different regions.
The original brand is produced by Novartis, and several other licensed manufacturers produce generic versions globally.
The generic name is Eltrombopag, commonly in the form of eltrombopag olamine.
Brand names include Promacta and Revolade.
It is manufactured in multiple countries through Novartis facilities and approved global generic manufacturers.
Related Products
Luspatercept,
Strength:
25 mg, 75 mg
Form: Lyophilized powder for subcutaneous injection
Reference Brands: Reblozyl
View Details
Hydroxyurea
Strength:
Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg
Form: Capsules and Tablets
Reference Brands: Hydrea, Droxia , Siklos
View Details
Folic Acid
Strength:
0.4 mg, 0.6 mg, 0.8, 1mg, 2.5 mg & 5mg
Form: Tablets
Reference Brands: Folvite, Folacin, Acifol
View Details
Crizanlizumab
Strength:
100 mg/10 mL (10 mg/mL)
Form: IV Infusion
Reference Brands: Adakveo®(EU & US)
View Details
Quick Response Guaranteed | Verified Suppliers
